Houlihan Lokey (NYSE:HLI - Get Free Report) had its price objective upped by equities researchers at UBS Group from $229.00 to $230.00 in a research report issued to clients and investors on Wednesday,Benzinga reports. The firm presently has a "buy" rating on the financial services provider's stock. UBS Group's price objective would indicate a potential upside of 27.69% from the stock's previous close.
Other analysts also recently issued research reports about the stock. StockNews.com raised shares of Houlihan Lokey from a "hold" rating to a "buy" rating in a research report on Tuesday. Wells Fargo & Company dropped their target price on shares of Houlihan Lokey from $180.00 to $178.00 and set an "underweight" rating for the company in a research report on Tuesday, January 14th. Morgan Stanley cut shares of Houlihan Lokey from an "equal weight" rating to an "underweight" rating and increased their price target for the stock from $171.00 to $200.00 in a research report on Monday, December 9th. Keefe, Bruyette & Woods lowered their price objective on Houlihan Lokey from $172.00 to $170.00 and set a "market perform" rating for the company in a report on Monday, January 13th. Finally, JPMorgan Chase & Co. reduced their target price on Houlihan Lokey from $172.00 to $169.00 and set a "neutral" rating on the stock in a report on Wednesday. Two equities research analysts have rated the stock with a sell rating, three have given a hold rating and two have assigned a buy rating to the stock. According to MarketBeat, Houlihan Lokey currently has an average rating of "Hold" and an average price target of $194.40.
Get Our Latest Report on HLI
Houlihan Lokey Stock Performance
HLI traded up $0.33 on Wednesday, reaching $180.13. 613,351 shares of the company's stock were exchanged, compared to its average volume of 448,729. Houlihan Lokey has a twelve month low of $119.28 and a twelve month high of $192.10. The company's 50 day moving average is $179.10 and its 200-day moving average is $166.69. The company has a market cap of $12.52 billion, a price-to-earnings ratio of 36.84 and a beta of 0.69.
Houlihan Lokey (NYSE:HLI - Get Free Report) last released its quarterly earnings data on Tuesday, January 28th. The financial services provider reported $1.64 earnings per share (EPS) for the quarter, topping the consensus estimate of $1.51 by $0.13. Houlihan Lokey had a net margin of 15.77% and a return on equity of 19.29%. Sell-side analysts forecast that Houlihan Lokey will post 5.74 EPS for the current year.
Hedge Funds Weigh In On Houlihan Lokey
Large investors have recently made changes to their positions in the business. Financial Life Planners acquired a new stake in shares of Houlihan Lokey during the 4th quarter valued at about $33,000. Wolff Wiese Magana LLC bought a new position in Houlihan Lokey during the third quarter valued at approximately $38,000. Golden State Wealth Management LLC acquired a new stake in Houlihan Lokey in the fourth quarter valued at approximately $53,000. First Horizon Advisors Inc. grew its position in Houlihan Lokey by 81.5% in the third quarter. First Horizon Advisors Inc. now owns 441 shares of the financial services provider's stock worth $70,000 after acquiring an additional 198 shares in the last quarter. Finally, Quarry LP acquired a new position in shares of Houlihan Lokey during the 3rd quarter worth $76,000. Institutional investors and hedge funds own 78.07% of the company's stock.
Houlihan Lokey Company Profile
(
Get Free Report)
Houlihan Lokey, Inc, an investment banking company, provides merger and acquisition (M&A), capital market, financial restructuring, and financial and valuation advisory services worldwide. It operates in three segments: Corporate Finance, Financial Restructuring, and Financial and Valuation Advisory.
Read More
Before you consider Houlihan Lokey, you'll want to hear this.
MarketBeat keeps track of Wall Street's top-rated and best performing research analysts and the stocks they recommend to their clients on a daily basis. MarketBeat has identified the five stocks that top analysts are quietly whispering to their clients to buy now before the broader market catches on... and Houlihan Lokey wasn't on the list.
While Houlihan Lokey currently has a "Reduce" rating among analysts, top-rated analysts believe these five stocks are better buys.
View The Five Stocks Here
Enter your email address and we'll send you MarketBeat's list of seven best retirement stocks and why they should be in your portfolio.
Get This Free Report
Like this article? Share it with a colleague.
Link copied to clipboard.